Jason Prestinario is CEO of Particle Health. The company is best known for its current lawsuit against Epic, but behind that there is a real company delivering a set of products as on ramp for clients wanting to access health data. Particle was cut off from access to Carequality & Epic a couple of years…
This brief focuses on consumers’ understanding of health insurance costs and examines existing federal protections that seek to address barriers to understanding the cost of coverage and care, such as price transparency, self-service price estimator tools, and simplifying cost-sharing designs.
This brief looks at premium changes for Medicare Part D stand-alone prescription drug plans between 2025 and 2026. For plans that were offered nationwide in 2025 and will continue to be offered in 2026, Part D enrollees in many states will see lower monthly premiums in 2026.
Nourish’s Series B round was led by J.P. Morgan Private Capital’s Growth Equity Partners. In total, the company has raised $115 million. The post Nourish Lands $70M to Fight Chronic Disease with Nutrition Care appeared first on MedCity News.
[Sponsored] They shared new developments, their views on AI, and what they’re doing to disrupt the status quo in healthcare. The post Heard at HLTH 2025: Healthcare Executives Highlight AI, ROI, and Fertility Tech. (Video) appeared first on MedCity News.
Rob Kennedy mingled with about a dozen other people in a community space in Clarks Summit, Pennsylvania. The room, decorated with an under-the-sea theme, had a balloon arch decked out with streamers meant to look like jellyfish and a cloud of clear balloons mimicking ocean bubbles. Kennedy comes to this memory cafe twice a month…
Despite AI’s growing ability to simulate empathy and even outperform humans in some areas of emotional awareness, can it truly replace human therapists and take the burden off the mental health care system? The post Why AI Won’t Replace Human Psychotherapists appeared first on MedCity News.
Jake Leach became DexCom’s chief executive on January 1 and is trying to write the turnaround story of this innovative medtech company. One story to tell is how CGMs should be a no-brainer for type 2 diabetes patients on GLP-1 weight loss drugs. The post DexCom’s CEO Believes Diabetics On GLP-1s Should Also Wear CGMs…
A Texas boy’s second dose of the MMRV vaccine cost over $1,400. A Pennsylvania woman’s long-acting birth control cost more than $14,000. Treatment for a Florida Medicaid enrollee’s heart attack cost nearly $78,000 — about as much as surgery for an uninsured Montana woman’s broken arm. In 2025, these patients were among the hundreds who…